1995
DOI: 10.1007/bf01931099
|View full text |Cite
|
Sign up to set email alerts
|

A convulsant, 3-mercaptopropionic acid, decreases the level of GABA and GAD in rat pancreatic islets and brain

Abstract: To investigate the properties of the gamma-aminobutyric acid (GABA) synthesizing enzyme, glutamate decarboxylase (GAD), in the brain and the pancreatic islets of the rat, GABA concentration in the brain and the pancreatic islets was measured after intraperitoneal administration of 3-mercaptopropionic acid (3-MP) at 25 mg/kg. 60 min after the administration of 3-MP, GABA concentration in the hypothalamus, the superior colliculus and the hippocampus of the brain decreased by 20-30% and in the pancreatic islets b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2001
2001
2019
2019

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 19 publications
0
3
0
Order By: Relevance
“…Inhibition of GAD67 activity abolishes glucosestimulated insulin secretion (GSIS) in β-cells and young and aged islets Because GAD67 expression is significantly upregulated in response to increased glucose concentrations, we examined whether GAD67 activity affects the capacity of β-cells and islets to secrete insulin. We treated the β-TC6 cell line with 3-mercaptopropionic acid (3-MPA), a potent competitive inhibitor of GADs that is commonly used to modify GAD activity in rodent pancreatic islets and brain, [21][22][23] and did not observe effects on cell viability below 50 μM 3-MPA (Supplementary Figure 3A and B). Similarly, we tested primary islets isolated from young and aged mice.…”
Section: Elevated Gad67 Expression Does Not Cause Autoimmune Destructmentioning
confidence: 99%
“…Inhibition of GAD67 activity abolishes glucosestimulated insulin secretion (GSIS) in β-cells and young and aged islets Because GAD67 expression is significantly upregulated in response to increased glucose concentrations, we examined whether GAD67 activity affects the capacity of β-cells and islets to secrete insulin. We treated the β-TC6 cell line with 3-mercaptopropionic acid (3-MPA), a potent competitive inhibitor of GADs that is commonly used to modify GAD activity in rodent pancreatic islets and brain, [21][22][23] and did not observe effects on cell viability below 50 μM 3-MPA (Supplementary Figure 3A and B). Similarly, we tested primary islets isolated from young and aged mice.…”
Section: Elevated Gad67 Expression Does Not Cause Autoimmune Destructmentioning
confidence: 99%
“…24 Furthermore, a number of interesting data concerning the expression and physiological functions of the GAD isoenzymes from mammalian tissues have been published in recent years. [25][26][27][28] Other authors describe the influence of certain convulsants [29][30][31] and anticonvulsants 16,32 on GABA levels in brain tissues. According to an early report, the 4′-substituted vitamin B 6 derivative 4′-deoxypyridoxine (4, Figure 1) was shown to be a potent inhibitor of GAD.…”
Section: Introductionmentioning
confidence: 99%
“…According to experiments with recombinant enzymes, GAD 65kDa seems to be more responsive than GAD 67kDa , but the differences have not as yet been characterized Other authors describe the influence of certain convulsants and anticonvulsants , on GABA levels in brain tissues. According to an early report, the 4‘-substituted vitamin B 6 derivative 4‘-deoxypyridoxine ( 4 , Figure ) was shown to be a potent inhibitor of GAD .…”
Section: Introductionmentioning
confidence: 99%